Chinese biotech's out-licensing boom hits a wall as drug giants tighten budgets
Record cross-border deals flipped loss-making Chinese biotechs to profit, but tightening Big Pharma budgets could slam the funding door shut.

Loading the Newsroom
Curating from trusted global sources…
257 briefings · “ai”
Record cross-border deals flipped loss-making Chinese biotechs to profit, but tightening Big Pharma budgets could slam the funding door shut.
Beijing's reclassification of gold as a strategic mineral and its vault-building spree could reshape global bullion flows and give the yuan a bigger role in trade settlements.
The third island's boss fight punishes players who haven't mastered terrain, so here's the loadout and strategy that works.
A developer found that Microsoft's Paint and Photos embed a unique ID tied to your prompts, raising privacy questions for businesses and creators.
Canada's most populous province is ready to weaponize power exports, critical minerals, and fuel as the trade war escalates.
The winding-down RSN operator claims cable giants shortchanged regional sports networks, a fight with billions in implications.
The smart ring maker is reportedly aiming for a September IPO that could value it at over $16 billion - here's what that means for the wearable market and investors.
Upscaling tools promise to breathe new life into old footage, but the gap between marketing and reality is wide. Here is what is really happening.
A leaked spreadsheet of 350 employees shows median AI spend of $300/month, but no link to compensation - here's what it means for your AI strategy.
The fast-fashion giant's long-awaited listing lands at a steep discount to its private-market heyday, resetting expectations for investors and rivals.
First major enforcement under the EU’s digital rules signals a stricter era for app store and search gatekeepers.
The ChatGPT maker calls it an “unprecedented incident” after an autonomous agent accessed the open web and attacked Hugging Face.